{
  "main_header": {
    "sid": 1292730,
    "name": "Korro Bio, Inc.",
    "stock_name": "Korro Bio, Inc.",
    "full_name": "Korro Bio, Inc.",
    "name_url": "stocks-analysis/korro-bio-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "7.88",
    "chg": 0.06,
    "chgp": "0.77%",
    "dir": 1,
    "prev_price": "7.82",
    "mcapval": "309.20",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US5009461089",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "367.36 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/korro-bio-inc-1292730-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Korro Bio, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/korro-bio-inc-financial-trend-shifts-from-positive-to-negative-amid-declining-profits-and-stock-performance-3715763",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KorroBioInc_fintrenddot_3715763.png",
        "date": "2025-11-19 15:54:18",
        "description": "Korro Bio, Inc. reported net sales of USD 4.01 million for the quarter ending June 2025, reflecting improved revenue generation and cost management. However, the company struggles with a significant operating loss and declining earnings per share. Its debtors turnover ratio indicates effective collection practices amid ongoing market challenges."
      },
      {
        "title": "Korro Bio Forms Golden Cross, Signaling Potential Bullish Breakout Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/korro-bio-forms-golden-cross-signaling-potential-bullish-breakout-ahead-3595309",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/KorroBioInc_goldencross_3595309.png",
        "date": "2025-10-06 15:35:42",
        "description": "Korro Bio, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock has outperformed the S&P 500, with a notable monthly increase of 77.53%. Despite mixed technical indicators, Korro Bio's one-year performance of 47.67% highlights its strong market position and investor interest."
      }
    ],
    "total": 6,
    "sid": "1292730",
    "stock_news_url": "https://www.marketsmojo.com/news/korro-bio-inc-1292730"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Korro Bio, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Performance

2025-11-19 15:54:18

Korro Bio, Inc. reported net sales of USD 4.01 million for the quarter ending June 2025, reflecting improved revenue generation and cost management. However, the company struggles with a significant operating loss and declining earnings per share. Its debtors turnover ratio indicates effective collection practices amid ongoing market challenges.

Read More

Korro Bio Forms Golden Cross, Signaling Potential Bullish Breakout Ahead

2025-10-06 15:35:42

Korro Bio, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock has outperformed the S&P 500, with a notable monthly increase of 77.53%. Despite mixed technical indicators, Korro Bio's one-year performance of 47.67% highlights its strong market position and investor interest.

Read More

View All News